Screening Endoscopy May Lower CRC - Related Mortality in Healthy Elderly
Risk for CRC - related mortality reduced with screening endoscopy for those older than 75 years who do not have significant comorbidities (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 12, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Internal Medicine, Oncology, Pathology, Geriatrics, Journal, Source Type: news
Colonoscopy Before Age 50 May Cut Colorectal Cancer Risk in Women
Reduced risk seen with earlier initiation of endoscopy, including lower risk for colorectal cancer diagnosed in women before 55 years of age (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 12, 2017 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Gynecology, Internal Medicine, Oncology, Pathology, Journal, Source Type: news
7 medtech stories we missed this week: Aug. 18, 2017
[Image from unsplash.com]From Nemaura’s new Oceania distribution deal to Sanuwave’s promissory note expansion, here are seven medtech stories we missed this week but thought were still worth mentioning.
1. Nemaura inks Oceania distribution deal for SugarBeat patch
Nemaura announced in an Aug. 15 press release that it has signed a non-binding distribution deal with Device Technologies for exclusive rights to market the SugarBeat glucose monitoring system in Australia and New Zealand. The SugarBeat is a disposable, adhesive skin patch that is used by diabetics, providing a non-invasive and needle-free method of c...
Source: Mass Device - August 18, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Diabetes Diagnostics Implants Orthopedics Research & Development Surgical Brenner Medical Clinical Innovations Device Technologies K2M Masimo MedTech Nemaura Medical Sanuwave Si-Bone Source Type: news
Less-invasive Surgery Better for Very High-risk Patients With Necrotizing Pancreatitis Less-invasive Surgery Better for Very High-risk Patients With Necrotizing Pancreatitis
In the highest-risk patients with necrotizing pancreatitis, endoscopic and minimally invasive surgical necrosectomy are associated with lower mortality risk than open necrosectomy, according to data pooled from 15 cohorts in eight countries.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 16, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news
7 medtech stories we missed this week: June 23, 2017
[Image from unsplash.com]From Guardant suing Foundation Medicine to Interson receiving 510(k) clearance for ultrasound probes, here are 7 medtech stories we missed this week but thought were still worth mentioning.
1. Guardant levels false advertising suit against Foundation Medicine
Guardant Health announced in a June 22 press release that it has filed a lawsuit against Foundation Medicine for false advertising and unfair competition. Guardant Health is claiming that Foundation Medicine’s advertising causes harm to Guardant Health and its patients because it misleads oncologists about the sensitivity and accuracy of the...
Source: Mass Device - June 23, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Business/Financial News Clinical Trials Food & Drug Administration (FDA) Implants Neurological Regulatory/Compliance Ultrasound EndoStim Foundation Medicine Inc. Guardant Health Interson Lee's Pharmaceutical Meditech Med Source Type: news
Challenging tradition: Can appendicitis be treated solely with medication?
For 130 years, surgery has been the standard treatment for appendicitis — inflammation of the appendix, a short tube extending from the colon.After all, it ’s best to remove an infected body part that is not essential to survival rather than risk a rupture that spews bacteria into the abdomen. Right? Maybe not.UCLADr. David TalanDr. David Talan, professor in the department of emergency medicine at the David Geffen School of Medicine at UCLA, is helping to lead a $12-millionclinical trial to determine whether treating appendicitis solely with antibiotics can be a safe, effective and less expensive alternative to surgery...
Source: UCLA Newsroom: Health Sciences - March 9, 2017 Category: Universities & Medical Training Source Type: news
Even Without PPI, Oozing Peptic Ulcers Rarely Rebleed After Endoscopic Hemostasis Even Without PPI, Oozing Peptic Ulcers Rarely Rebleed After Endoscopic Hemostasis
The rebleeding rate of oozing peptic ulcer bleeds (PUB) after successful endoscopic therapy is low, and 72 hours of IV proton pump inhibitor (PPI) does not lower the rate further, according to results of a large multinational randomized trial.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - February 16, 2017 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Creo Medical looks to raise $25m in UK IPO
U.K.-based electrosurgery device developer Creo Medical said today it looks to raise $25.3 million (UK £20 million) in a U.K. initial public offering, expected to take place on December 9.
Creo Medical said it plans to offer shares at approximately 97¢ per share (UK £0.79), while the company has an estimated market capitalization of approximately $77.7 million (UK £61.3 million).
The company is developing minimally invasive surgical devices, initially focused on gastrointestinal surgery and lung cancer, using the company’s Croma system which combines bipolar radiofrequency and microwave energy technology.
Creo M...
Source: Mass Device - December 6, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Initial Public Offering (IPO) Surgical Creo Medical Source Type: news
For malignant biliary obstruction, plastic stents may be cost-effective alternative
(American Society for Gastrointestinal Endoscopy) Preoperative biliary drainage (PBD) with stent placement has been commonly used for patients with malignant biliary obstruction. In PBD, the placement of fully covered self-expandable metal stents may provide better patency duration and a lower incidence of cholangitis compared with plastic stents. But a new study in the November issue of GIE: Gastrointestinal Endoscopy suggests that plastic stents may provide similar outcomes at a potential cost savings. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 3, 2016 Category: Global & Universal Source Type: news
How Common are Herniated Disks in Children?
Discussion
Intervertebral disk herniation occurs at the same locations in pediatric patients as adults with L4-L5 and L5-S1 being the most common. Patients often (30-60% for lumbar disk patients) have a direct trauma or sports related injury that is identified before the onset of pain. There is also a group of morbidly obese patients who probably have degenerative disease. In adults and children, lumbar disk herniation is also seen with repetitive or excessive axial loading, poor conditioning, decreased range of motion and history of prior back injury. Disk herniation is caused by vertebral motion that causes increased int...
Source: PediatricEducation.org - September 19, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Incidence of cancer in patients with large colorectal polyps lower than previously thought
For the majority of patients with large or difficult to remove colorectal polyps (growths in the colon), the incidence of cancer is actually lower than previously thought, and using more advanced endoscopic techniques that spare the colon may be a better, safer alternative to a traditional operation in certain cases, according to study results. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 30, 2016 Category: Science Source Type: news
Incidence of cancer in patients with large colorectal polyps lower than previously thought
(American College of Surgeons) For the majority of patients with large or difficult to remove colorectal polyps (growths in the colon), the incidence of cancer is actually lower than previously thought, and using more advanced endoscopic techniques that spare the colon may be a better, safer alternative to a traditional operation in certain cases, according to study results published online in the Journal of the American College of Surgeons in advance of print publication. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 30, 2016 Category: Cancer & Oncology Source Type: news
Olympus slides on profit outlook despite swing to Q4, 2016 black
Shares in Olympus (TYO:7733) slid as much as -6.9% today before closing down -4.6% at roughly $33.67 (¥4,010.00), after the Japanese tech conglomerate said it expects lower sales and profits during its fiscal year ending next March.
Olympus said it expects sales to be off by -0.6% at about $7.46 billion (¥800 billion) for fiscal 2017. Operating profits could slide as much as -14% to $756 million (¥90 billion) due to the strong yen, the company said.
Earlier this week, Olympus said it swung to black for the 3 months and full year ended March 31, 2016. Profits were $165.8 million (¥19.74 billion) on sales of $1.78 bill...
Source: Mass Device - May 6, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Endoscopic / Arthroscopic MassDevice Earnings Roundup Wall Street Beat Olympus Source Type: news
St. Jude Medical’s Axium chronic pain device makes its U.S. debut
St. Jude Medical (NYSE:STJ) today announced the U.S. debut of its Axium neurostimulator system, after the device won FDA approval in February for treating chronic pain.
The 1st patients were implanted in West Virginia and California with the Axium device, which uses dorsal root ganglion stimulation to treat moderate to severe chronic intractable pain of the lower limbs in adult patients with complex regional pain syndrome, St. Jude said. The Axium is slated to be implanted in 25 states in the coming weeks, with 100 procedures due in the 1st month after launch, the Little Canada, Minn.-based company said.
“Si...
Source: Mass Device - April 11, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Neuromodulation/Neurostimulation Pain Management Wall Street Beat St. Jude Medical Source Type: news
Verb Surgical CEO Heunnekens says company is focusing on “digital surgery”
Verily and Johnson & Johnson‘s (NYSE:JNJ) collaborative business Verb Surgical looks to set the stage for a new style of robotic surgery, called “digital surgery,” according to an interview with CEO Scott Huennekens.
Verb Surgical aims to develop a comprehensive surgical platform that incorporates “leading edge” robotic capabilities and medical technology for use in the operating room, according to Johnson & Johnson. The company plans to develop them in partnership with surgeons and hospitals with a goal of “greater hospital efficiency.”
“First of all, we think of us no...
Source: Mass Device - April 4, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Research & Development Robot-Assisted Surgery Robotics Surgical Intuitive Surgical Inc. Johnson & Johnson Verb Surgical Verily Source Type: news
